Mode
Text Size
Log in / Sign up

Electrical Acupoint Stimulation May Speed Gut Recovery After Gastric Cancer SurgeryElectrical Acupoint Stimulation May Speed Recovery After Gastric Surgery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
EAS was linked to earlier flatus, defecation, and liquid intake after gastric cancer surgery, but not shorter hospital stay.

This meta-analysis examined whether electrical acupoint stimulation (EAS) improves postoperative gastrointestinal recovery in patients undergoing gastrectomy for gastric cancer. Across 1,357 patients, EAS was associated with earlier return of bowel function compared with no EAS.

Time to first flatus was reduced by a mean difference of 9.61 hours (95% CI, -12.81 to -6.42), though heterogeneity was high (I2 = 82.6%). Time to first defecation fell by 15.88 hours (95% CI, -23.31 to -8.46; I2 = 90.3%), and time to first liquid intake decreased by 10.65 hours (95% CI, -18.20 to -3.10; I2 = 0%).

Length of hospital stay did not differ significantly (MD, -0.63 days; 95% CI, -1.36 to 0.10; I2 = 57.0%). Certainty of evidence was very low for flatus and low for the other outcomes. Safety data were limited, with no serious adverse events reported where assessed.

These findings suggest a consistent directional signal favoring EAS for early gastrointestinal recovery milestones, but the magnitude, reproducibility, and clinical importance of the association remain uncertain. High heterogeneity and potential publication bias for flatus warrant cautious interpretation.

How this fits prior evidence

This meta-analysis addresses a gap in postoperative management for gastric cancer patients. While previous evidence established that PD-1/PD-L1 inhibitor plus chemotherapy improves overall survival in advanced gastric cancer, this study focuses on the immediate postoperative recovery period. The findings provide a consistent directional signal for using electrical acupoint stimulation to improve gastrointestinal milestones, though the evidence is limited by high heterogeneity and low certainty.

Researchers analyzed data from 1,357 patients who underwent surgery for gastric cancer. The study looked at how electrical acupoint stimulation (EAS) affected recovery milestones, such as passing gas, having a bowel movement, and starting liquid intake after the procedure.

The results showed that patients who received the treatment reached these milestones faster. Specifically, the study found shorter times for the first flatus, first defecation, and first liquid intake. However, the study did not find a significant difference in the total length of hospital stay for those who received the treatment.

It is important to note that the evidence for these findings is currently limited. The study showed high variation in the data for gas and bowel movements, and there was limited reporting on safety. Because the evidence is not yet certain, these results should be viewed as a preliminary look at how the treatment might help patients recover faster after surgery.

What this means for you:
Electrical acupoint stimulation may help patients reach recovery milestones faster after gastric cancer surgery.

Common questions

How does electrical acupoint stimulation help after surgery?

The study found that electrical acupoint stimulation (EAS) was linked to shorter times for passing gas (flatus), first defecation, and first liquid intake after surgery for gastric cancer. While it showed a positive direction for these recovery milestones, the evidence for these specific results is currently considered to have low to very low certainty.

Does this treatment shorten the time spent in the hospital?

The study analyzed the length of hospital stay for patients undergoing gastrectomy for gastric cancer. The results showed no significant difference in the total length of stay between those who received the treatment and the comparison group, with a mean difference of only 0.63 days.

Is this treatment safe for patients after gastric surgery?

The study did not report any serious adverse events where assessed. However, there was limited reporting on overall safety and tolerability. Because the evidence is still early and limited, you should talk to your doctor about the best recovery plan for your specific needs.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Delayed gastrointestinal recovery remains a challenge after gastrectomy for gastric cancer, with residual variability even within enhanced recovery after surgery (ERAS) pathways. This residual variability has prompted interest in adjunctive approaches such as electrical acupoint stimulation (EAS), but gastrectomy-specific anatomical and neural features may limit extrapolation from broader abdominal-surgery populations. We therefore synthesized randomized evidence on EAS for postoperative gastrointestinal recovery and examined variation across study-level characteristics. We searched PubMed, Embase, Scopus, CENTRAL, China National Knowledge Infrastructure, Wanfang Data, SinoMed, and four registries from inception to a 1 August 2026 cutoff. We included randomized trials in patients undergoing gastrectomy for gastric cancer when EAS was separable from other traditional or acupoint-based co-interventions. Outcomes were time to first flatus (primary), first defecation, first liquid intake, and length of hospital stay. Safety was summarized descriptively. Risk of bias was assessed with the Cochrane Risk of Bias 2 tool and certainty with GRADE; exploratory subgroup differences were examined using interaction tests. Fifteen trials were eligible; 13 contributed to the primary pairwise comparison (1,357 participants) and two to narrative synthesis only. EAS was associated with shorter times to first flatus [13 trials; mean difference (MD), −9.61 h; 95% CI, −12.81 to −6.42; I2 = 82.6%; very low certainty], first defecation (9 trials; MD, −15.88 h; 95% CI, −23.31 to −8.46; I2 = 90.3%; low certainty), and first liquid intake (2 trials; MD, −10.65 h; 95% CI, −18.20 to −3.10; I2 = 0%; low certainty). Length of hospital stay did not differ significantly (7 trials; MD, −0.63 days; 95% CI, −1.36 to 0.10; I2 = 57.0%; low certainty). Prediction intervals narrowly excluded the null for flatus but included it for defecation. For flatus, funnel-plot asymmetry and trim-and-fill attenuation raised publication-bias concerns. None of the 12 primary interaction tests across comparator design, perioperative care, stimulation modality, and frequency strategy was significant. Safety reporting was limited; no serious intervention-related adverse events were reported where assessed. Current evidence indicates a consistent directional signal favoring EAS for early postoperative gastrointestinal recovery milestones, but the magnitude, reproducibility, and clinical importance of this association remain uncertain. Systematic Review Registration:https://www.crd.york.ac.uk/PROSPERO/view/CRD420261289414, identifier CRD420261289414.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.